Publication:
Omalizumab treatment in childhood chronic urticaria

dc.contributor.authorÇekiç, Şükrü
dc.contributor.authorKarali, Yasin
dc.contributor.authorCanıtez, Yakup
dc.contributor.authorSapan, Nihat
dc.contributor.buuauthorÇEKİÇ, ŞÜKRÜ
dc.contributor.buuauthorKARALI, YASİN
dc.contributor.buuauthorCANITEZ, YAKUP
dc.contributor.buuauthorSAPAN, NİHAT
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatri ve Alerji Bölümü
dc.contributor.orcid0000-0002-9574-1842
dc.contributor.researcheridL-1933-2017
dc.contributor.researcheridFFS-1974-2022
dc.contributor.researcheridCJQ-2060-2022
dc.contributor.researcheridFUI-8766-2022
dc.date.accessioned2024-07-25T12:49:05Z
dc.date.available2024-07-25T12:49:05Z
dc.date.issued2018-08-01
dc.descriptionBu çalışma, 26-30, Mayıs 2018 tarihlerinde Munich[Almanya]’da düzenlenen Congress of the European-Academy-of-Allergy-and-Clinical-Immunology (EAACI) Kongresi‘nde bildiri olarak sunulmuştur.
dc.description.sponsorshipEuropean Acad Allergy & Clin Immunol
dc.identifier.eissn1398-9995
dc.identifier.endpage227
dc.identifier.issn0105-4538
dc.identifier.startpage227
dc.identifier.urihttps://hdl.handle.net/11452/43448
dc.identifier.volume73
dc.identifier.wos000441690401184
dc.indexed.wosWOS.SCI
dc.indexed.wosWOS.ISTP
dc.language.isoen
dc.publisherWiley
dc.relation.journalAllergy
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectAllergy
dc.subjectImmunology
dc.titleOmalizumab treatment in childhood chronic urticaria
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublicationca52bf41-6be5-42a5-b2c5-f219305eba24
relation.isAuthorOfPublication0a2bfa05-0e6e-4f99-ae52-704e9dc7a4f5
relation.isAuthorOfPublication6b5d010e-4bcd-498b-8e2c-3d59ff1edb47
relation.isAuthorOfPublicationcc312521-b6b8-4031-a0a0-b06b35291a1c
relation.isAuthorOfPublication.latestForDiscoveryca52bf41-6be5-42a5-b2c5-f219305eba24

Files

Collections